Ceramide NP — previously classified as Ceramide 3 under the older nomenclature system — is a sphingolipid and the most abundant ceramide species found in the human stratum corneum, comprising approximately 20–25% of total ceramide content in healthy skin. Its INCI name follows the current IPC (International Nomenclature for Ceramides) classification: NP denotes a non-hydroxy fatty acid (N) paired with a sphingosine (phytosphingosine base variant: P — though "NP" in INCI denotes non-hydroxy + phytosphingosine in the IPC system; note that labelling conventions vary by country).
Ceramides as a class constitute approximately 40–50% of the total lipid content of the stratum corneum by weight. These lipids are organized into lamellar bodies within keratinocytes during skin maturation, and are subsequently secreted into the intercellular space of the stratum corneum where they self-assemble into highly ordered lamellar bilayers. This bilayer architecture — composed primarily of ceramides, cholesterol, and free fatty acids in a tightly regulated molar ratio — forms the physical barrier that regulates transepidermal water loss (TEWL), prevents penetration of environmental irritants and allergens, and maintains the integrity of the skin surface.
When ceramide levels are depleted — through aging, harsh detergent exposure, excessive exfoliation, UV damage, genetic predisposition (as in atopic dermatitis), or cold/dry weather — the lamellar bilayer becomes disorganized. TEWL rises, skin becomes dry and tight, the barrier becomes permeable to irritants, and inflammatory conditions such as eczema and rosacea are more easily triggered. Topical application of ceramide NP replenishes the intercellular lipid pool, restoring lamellar architecture and barrier function.
Ceramide NP is a skin-identical ingredient — meaning it is chemically equivalent to the ceramide species naturally produced by the skin. When applied topically in an appropriate delivery vehicle (typically an emulsion), ceramide NP molecules integrate into the existing intercellular lamellar bilayer of the stratum corneum, physically filling gaps caused by ceramide depletion. This is a structural, not a signalling mechanism — ceramide NP acts as a direct building block rather than as a receptor agonist or enzyme modulator.
The effectiveness of topical ceramide delivery is highly dependent on formulation design. Ceramide NP requires cholesterol and free fatty acids as co-lipids to successfully assemble into lamellar structures within the stratum corneum. Research by Mao-Qiang, Feingold, and colleagues established that the optimal molar ratio for barrier repair is ceramide:cholesterol:free fatty acid = 3:1:1. Formulations deviating significantly from this ratio — particularly those with excess free fatty acids — can paradoxically impair barrier function.
Ceramide NP should be formulated alongside cholesterol and fatty acids in a molar ratio of 3:1:1. This is not a guideline — it reflects the composition of the stratum corneum lamellar bilayer. Deviation from this ratio, especially excess fatty acids, can disrupt rather than repair barrier function.
The clinical evidence base for ceramide NP is anchored in the well-established connection between ceramide depletion and barrier dysfunction. In atopic dermatitis (AD), multiple studies have documented a consistent reduction in total ceramide content — particularly ceramide NP — compared to healthy controls, with the degree of depletion correlating with disease severity. This biochemical link provided the scientific rationale for ceramide replacement therapy as a first-line adjunct to AD management.
A landmark 2014 review published in the Journal of the European Academy of Dermatology and Venereology (van Smeden et al.) comprehensively characterized the stratum corneum lipid composition in AD and demonstrated that ceramide NP was the most significantly depleted ceramide species. Subsequent intervention studies using ceramide-containing emollients showed measurable reductions in TEWL, improvements in skin hydration scores, and reduced steroid use in AD patients.
For non-atopic dry skin, a 2010 randomized controlled trial demonstrated that a ceramide NP-containing formulation at 0.1–0.5% significantly improved skin hydration (corneometry) and reduced TEWL compared to vehicle over 4 weeks of twice-daily application — establishing efficacy at cosmetic use concentrations in non-pathological dry skin conditions.
| INCI Name | Ceramide NP |
| Former Name | Ceramide 3 (older CTFA nomenclature) |
| CAS Number | 24696-26-2 |
| Chemical Class | Sphingolipid — N-acylsphingosine |
| Structure | Non-hydroxy fatty acid (C16:0 palmitic acid) + sphingosine base; chain length varies by source |
| Appearance | White to off-white waxy solid or powder |
| Solubility | Insoluble in water; soluble in chloroform, ethanol (warm), IPM; requires emulsification for aqueous systems |
| Melting Point | Approximately 90–95°C (varies by chain length/source) |
| Recommended Usage | 0.2% – 2.0% (in ceramide complex; typically 3:1:1 with cholesterol and fatty acid) |
| Phase | Oil phase or pre-dissolved/pre-melted in emollient |
| Origin / Source | Synthetic (petrochemical or fermentation-derived) or plant-derived (wheat germ, soybean, rice bran) |
| Regulatory Status | CosIng listed | FDA compliant | CDSCO compliant | IECIC listed |
Ceramide NP is a skin-identical lipid with an excellent safety and tolerability record. It is recommended as a first-line ingredient even for the most sensitive skin types, including neonates, atopic dermatitis patients, and post-procedure skin.
| Sensitization | Non-sensitizing — skin-identical molecule; no foreign immune response elicited |
| Comedogenicity | Non-comedogenic at cosmetic use levels; physiological lipid replenishment does not occlude follicles |
| Irritation Potential | Non-irritating — used in formulations for atopic and reactive skin types |
| Photosensitivity | Non-photosensitizing |
| Special Populations | Safe and beneficial during pregnancy, lactation, and neonatal skincare; standard of care for pediatric atopic dermatitis management |
| Eyes | Avoid direct eye contact; suitable for periorbital formulations at low concentrations in appropriate vehicle |
Ceramide NP is a waxy solid that is insoluble in water and must be incorporated into the oil phase of emulsions, or pre-dissolved in a suitable emollient (e.g. isopropyl myristate, caprylic/capric triglyceride) at elevated temperature before emulsification. It is not self-emulsifying and requires an appropriate emulsifier system to achieve a stable, aesthetically acceptable formulation. The critical formulation principle is the ceramide:cholesterol:free fatty acid ratio — deviation from approximately 3:1:1 (molar) is one of the most common formulation errors in ceramide product development.
Core application — rich emulsions with cholesterol and fatty acid co-lipids for clinical-grade barrier restoration
Adjunct therapy — reduces TEWL and steroid dependency; standard in paediatric eczema management protocols
Addresses age-related ceramide depletion; reduces TEWL, plumps dry skin, improves texture
Gentle barrier reinforcement for reactive, rosacea-prone, and compromised skin
Barrier restoration after chemical peels, laser, microneedling, or retinoid use
Physiologically appropriate barrier support for immature neonatal skin
Barrier support for periorbital zone; reduces dry crepiness around the eyes
Anhydrous or low-water formats; ceramide NP integrates directly into lip barrier lipid matrix
| Minimum Efficacious | 0.2% w/w (in appropriate 3:1:1 complex) |
| Standard Range | 0.5 – 1.0% w/w (most clinical and consumer studies) |
| High Dose | 2.0% w/w (intensive barrier repair; clinical-grade formulations) |
For optimal barrier repair efficacy, formulate ceramide NP alongside cholesterol and a free fatty acid (typically stearic acid or palmitic acid) in a molar ratio of 3:1:1. In practice, a commonly used weight-based starting point is approximately 3 parts ceramide NP : 1 part cholesterol : 1 part free fatty acid by weight (precise molar ratio will depend on the specific fatty acid chain length used). This ratio mirrors the composition of the stratum corneum lamellar bilayer and has been validated in multiple barrier repair studies.
Pre-melt the ceramide complex together in a suitable emollient carrier at 85–95°C until clear, then incorporate into the oil phase of your emulsion. Do not add cold — the high melting point of ceramide NP requires full melting to achieve uniform distribution and stable emulsification.
| Compatible With | Use Caution With |
|---|---|
| Cholesterol and free fatty acids (essential co-lipids) Niacinamide (complementary barrier mechanisms) Hyaluronic acid, glycerin, panthenol Ectoin (barrier + cellular protection synergy) Allantoin, centella asiatica Retinoids (ceramide buffers retinoid-induced barrier disruption) Most emollient and emulsifier systems | High-surfactant formulations — excess surfactant disrupts lamellar bilayer assembly Strong exfoliants (high-dose AHA/BHA) — may counteract barrier repair benefit Incorrect lipid ratios — excess fatty acid alone can impair barrier; always include cholesterol |
Ceramide NP is available from multiple established global suppliers in both synthetic and plant-derived (wheat germ, soybean, rice bran) forms. SBCT Labs does not currently manufacture ceramide NP as a standalone ingredient. For sourcing, we recommend suppliers including Evonik (TEGO Ceramide series), Givaudan (Lipex Ceramide), and MakingCosmetics for cosmetic-grade ceramide NP with full technical documentation. We welcome formulation discussions around ceramide-containing barrier repair complexes.
Ceramide NP is universally accepted as a cosmetic ingredient with no concentration restrictions in any major market. As a skin-identical lipid, it faces no significant regulatory barriers globally and is categorised as a skin-conditioning agent in cosmetic ingredient databases.
Compliant with Indian Cosmetic Rules 2020. No concentration restrictions for topical use. Ceramide NP is widely used and accepted in the Indian cosmetic market with no documented safety concerns.
Listed in the CosIng database as a skin-conditioning agent. No Annex restrictions. Fully compliant with Regulation (EC) No. 1223/2009. Extensively used in EU-marketed dermo-cosmetic and pharmaceutical skincare products.
No FDA restrictions for cosmetic use. Ceramide NP is present in numerous over-the-counter moisturizers, eczema care products, and prescription adjunct therapies marketed in the United States.
Listed in the Inventory of Existing Cosmetic Ingredients in China. Approved for use in cosmetic products. Ceramides are a key ingredient category in the rapidly growing Chinese premium skincare market.
A. These are different ceramide species differentiated by their sphingoid base and fatty acid head group. Ceramide NP (non-hydroxy fatty acid + phytosphingosine) is the most abundant ceramide in human skin. Ceramide AP (alpha-hydroxy fatty acid + phytosphingosine) and Ceramide EOP (ester-linked omega-hydroxy fatty acid + phytosphingosine) are other important species with slightly different structural roles in the lamellar bilayer. A comprehensive barrier repair formulation ideally incorporates multiple ceramide species — not just NP alone — to more accurately mimic the full ceramide profile of healthy stratum corneum.
A. Ceramide NP alone cannot form a functional lamellar bilayer. Cholesterol modulates fluidity and packing of the bilayer, preventing it from becoming too crystalline (rigid) or too liquid (leaky). Free fatty acids complete the three-lipid architecture essential to barrier function. Without cholesterol, ceramide NP over-crystallises and cannot integrate effectively. Without fatty acids, lamellar structure is incomplete. The 3:1:1 ratio is not aesthetic — it is the biologically functional minimum for structural barrier repair.
A. Functionally equivalent for most cosmetic applications. Plant-derived ceramide NP (from wheat germ, soybean, or rice bran) and synthetic ceramide NP have the same core molecular structure and barrier-repair mechanism. The primary difference is that plant-derived ceramides may contain a mixture of ceramide species and chain lengths, which can actually be advantageous for mimicking the diversity of the natural stratum corneum ceramide profile. Verify the purity and ceramide content certificate of your specific raw material.
A. Ceramide NP is not water-soluble and cannot be directly dissolved in an aqueous serum. Options include: (1) use a pre-made ceramide NP solubiliser/dispersion from a supplier (several suppliers offer water-dispersible ceramide complexes); (2) formulate as an emulsion (O/W or W/O) rather than a clear serum; (3) incorporate as a liposomal ceramide encapsulate; or (4) use a cyclodextrin-complexed ceramide where available. Attempting to add crystalline ceramide NP directly to an aqueous base will result in visible particles and instability.
A. Efficacy in barrier repair studies has been demonstrated from 0.1–0.5% ceramide NP in the correct complex. For dry skin conditioning, 0.2–0.5% in a 3:1:1 complex is sufficient for measurable TEWL reduction. For clinical-grade barrier repair (atopic skin, post-procedure), 0.5–2.0% in a well-designed emulsion is standard. Higher concentrations above 2% do not provide proportionally greater benefit and increase formulation cost and complexity.
A. Yes — and this is a recommended combination. Retinoids (retinol, retinal, tretinoin) accelerate skin cell turnover, which can transiently deplete stratum corneum ceramide content and cause the characteristic dryness, flaking, and sensitivity of retinoid adaptation. Incorporating ceramide NP in a retinoid formulation or barrier repair moisturizer used alongside retinoid treatment buffers this depletion, reduces irritation, and supports continued use — a strategy supported by multiple dermatologist-recommended skincare protocols.
Disclaimer: Information on this page has been compiled from published scientific literature and industry reference sources. Formulation recommendations are general guidelines and should be validated through appropriate stability and compatibility testing for your specific product. SBCT Labs makes no warranty, expressed or implied, regarding the suitability of information for any particular application. Users are responsible for verifying safety, efficacy, and regulatory compliance for their intended use.